Delivery Order SPE2DR25D3301-SPE2DR26F20WH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $21,516.67 to AmerisourceBergen Drug Corp for the supply of Mekinist 2 mg tablets (30-count units) on January 15, 2026, with completion scheduled for February 6, 2026. This firm fixed-price contract was competitively awarded without set-aside designation and will be performed at the awardee's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as...
- The Defense Logistics Agency awarded a delivery order valued at $7,806.61 to AmerisourceBergen Drug Corp for 90 milliliters of Mekinist 0.05 mg/ml solution, with a completion date of October 17, 2025. This competitively awarded, firm fixed-price contract was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,191.22 for 30 tablets of Mekinist 2 mg on December 23, 2025, with an ultimate completion date of January 15, 2026. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement of the oncology medication and contains no subcontractor information. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a Delivery Order valued at $11,195.23 to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 12, 2026, for the supply of Mekinist 2 mg tablets in quantities of 30. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by February 3, 2026. The awardee, based in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $48.7 million delivery order to AmerisourceBergen Drug Corp for the supply of Mekinist 2 mg tablets (30-count units) under a firm fixed-price contract type. This non-set-aside award was made on December 2, 2025, with an ultimate completion date of December 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the contract at its corporate office location. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Mekinist 0.05 mg/mL solution in a 90 mL quantity, with a ceiling value of $5,576.15. This is a firm fixed price delivery order with an ultimate completion date of November 10, 2025, and was competitively awarded without set-aside restrictions. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $19,566.67 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Mekinist 2 mg (a targeted cancer therapy medication) on December 16, 2025, with an ultimate completion date of January 8, 2026. This non-set-aside contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,390.46 to AmerisourceBergen Drug Corp for the supply of Mekinist 2 mg tablets (30-count units) with a completion date of February 9, 2026. The contract was awarded on January 16, 2026, using firm fixed-price pricing with no set-aside designation, indicating the award was made through full and open competition. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $8.55K to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Mekinist 0.5 mg tablets (30-count units). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 4, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $40,764.88 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Mekinist 2 mg tablets (30-count units) on November 3, 2025, with an ultimate completion date of November 25, 2025. This is a non-set-aside competitive award issued as a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where the contractor maintains its...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F20WHDelivery Order
The Defense Logistics Agency awarded a $8,351.98 delivery order to AmerisourceBergen Drug Corp for 90ml of Mekinist 0.05 mg/ml solution on January 16, 2026, with an ultimate completion date of February 9, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and will be performed at the awardee's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The IDC enables the contractor to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, encompassing specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The prime IDV serves customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through a flexible contract structure designed to meet diverse federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 1/15/26 |